The Epidemiology of Hemorrhoids: What the Real Numbers Are

Ask “how common are hemorrhoids?” and you’ll find answers ranging from about 4% to over 30%, sometimes on the same page of the same source. This isn’t sloppy reporting — it reflects genuinely different ways of measuring the same underlying condition, and it’s worth understanding the difference rather than repeating a single number as if it were the whole story.

Key takeaways

Studies based on people who report symptoms and seek care find lower prevalence (around 4%); studies that examine people directly (like during screening colonoscopy) find much higher rates.
Claims-based data (from insurance records) tends to show the lowest figures, since it only captures people who were formally diagnosed.
“Nearly half of adults by age 50” is a commonly cited lifetime-risk figure, distinct from current point-in-time prevalence — these are different metrics, not competing claims about the same thing.

Why the numbers vary so much

Four broadly different measurement approaches produce four different types of numbers:

1. Self-reported symptomatic prevalence. A classic, frequently cited study found about 4.4% of the US population reporting symptomatic hemorrhoids at a given time — this is probably the most commonly quoted figure in casual sources.

2. Direct examination studies. When people are examined directly regardless of whether they reported symptoms — for example, during a screening colonoscopy done for an unrelated reason — hemorrhoids are found far more often. One study found hemorrhoids present in nearly 39% of colonoscopy patients, with symptoms in a large share of those. This captures hemorrhoids that exist but weren’t necessarily reported or bothersome enough to seek care for.

3. Claims-based (insurance) data. Analyses based on formal diagnosis codes in insurance claims tend to show lower figures still — for example, a claims-based analysis among privately insured people found a prevalence around 2.7%, and around 4.2% among Medicare beneficiaries. These numbers reflect formally diagnosed cases specifically, undercounting anyone who never sought care or wasn’t formally coded.

4. Broader “up to X%” ranges cited in some clinical reviews. Some sources cite figures as high as 30–40%, generally reflecting broader definitions or specific subpopulations rather than general population point-prevalence — worth noting these aren’t necessarily wrong, but they’re answering a somewhat different question than the 4.4% figure.

What “50% by age 50” actually means

This widely repeated figure refers to lifetime risk — the chance of experiencing symptomatic hemorrhoids at some point by age 50 — not the share of 50-year-olds who currently have symptoms at any given moment. This is a genuinely different metric from point-in-time prevalence, and citing both figures on the same page without distinguishing them (a pattern this site’s original audit specifically flagged as a problem on other hemorrhoid websites) creates the false impression of contradictory data when they’re actually just answering different questions.

Why this matters for how this site uses statistics

Given this range, this site is careful to specify which type of figure is being cited and from which source, rather than presenting a single number as a universal fact — see the site’s editorial policy for the broader commitment behind this practice.

A reasonable way to summarize this for a general reader

Symptomatic hemorrhoids affecting someone at a given moment: commonly cited around 4–5% based on self-reported or claims data
Hemorrhoids present (whether symptomatic or not) if you looked directly: notably higher, approaching 40% in colonoscopy-based studies
Lifetime chance of experiencing symptoms at some point: often cited around 50% by age 50

These aren’t contradictory — they’re measuring different things, and all three can be true simultaneously.

Want to see how this connects to who’s affected and when across the lifespan? See Hemorrhoids by age.

This page is for general education, synthesizing figures from multiple published sources with different methodologies. Specific citations should be verified and linked directly at publication.